Header image

Poster Tour 1

Tracks
Track 2
Track 3
Monday, August 5, 2019
1:40 PM - 2:15 PM
Exhibition Area

Speaker

Ms Peta Gava
Project Officer
Peer Based Harm Reduction WA

NOTHING ABOUT US WITHOUT US: THE ROLE OF PEER EDUCATORS IN HCV TESTING AND TREATMENT UPTAKE.

1:40 PM - 1:45 PM

Abstract

Biography

Peta Gava is a peer worker who has been working at Peer Based Harm Reduction WA since 2016. She is also the Project Officer for the Hep C PHRE Project.
Ms Sahar Bajis
Postdoctorral Fellow
The Kirby Institute

HEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFE STUDY

1:45 PM - 1:50 PM

Abstract

Biography

Sahar Bajis is a PhD Candidate in the Viral Hepatitis Clinical Research Program at the Kirby Institute, UNSW Sydney
Dr Jake Williams
Advanced Trainee
St George Hospital

UNIVERSAL BLOOD-BORNE VIRUS SCREENING IN PATIENTS WITH SEVERE MENTAL ILLNESS MANAGED IN AN OUTPATIENT CLOZAPINE CLINIC: UPTAKE AND PREVALENCE

1:50 PM - 1:55 PM

Abstract

Biography

Currently in final year of advanced training in Infectious Diseases at St George Hospital. Practice interests include HIV medicine and viral hepatitis with a focus on rural/regional populations.
Dr Ingrid Francis
Gp With Special Interest
Gold Coast University Hospital

COLLABORATIVE APPROACH TO THE MANAGEMENT OF HEPATITIS C AT NUMINBAH QUEENSLAND CORRECTIONAL FACILITY

1:55 PM - 2:00 PM

Abstract

Biography

Ingrid Francis is a GP with Special interest working in the hepatology unit GCUH and community general practice. As a Queensland opiate treatment program prescriber, she has developed an interest in Hepatitis C and an appreciation of the complexities of treating people with social disadvantage, substance dependence, current/previous incarceration.
Dr Annie Balcomb
General Practitioner
Prince St Medical Practice

AUSTRALIAN RURAL PRIMARY CARE LED VIRAL HEPATITIS CLINIC - OUTCOME DATA FROM 3 YEARS OF DIRECT ACTING ANTIVIRAL AGENTS (DAA'S).

2:00 PM - 2:05 PM

Abstract

Biography

Dr Balcomb is a chronic hepatitis C (HCV) General Practitioner (GP) Prescriber with over 10 years experience, based in rural New South Wales. In 2016 she established a dedicated GP viral hepatitis clinic and is passionate about upskilling all GP’s regarding chronic viral hepatitis management.
Agenda Item Image
Dr Alisa Pedrana
Senior Research Fellow
Burnet Institute

HEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATA.

2:05 PM - 2:10 PM

Abstract

Biography

Dr Pedrana is the coordinator for the Eliminate hepatitis C (EC) Partnership, at the Burnet Institute.
Agenda Item Image
Ms Bridget Draper
Senior Research Officer
Burnet Institute

COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS AND GENERAL POPULATION IN MYANMAR

2:10 PM - 2:15 PM

Abstract

Biography

Bridget Draper is a PhD Candidate at Burnet Institute/Monash University. Her PhD focuses on how to provide hepatitis C testing and treatment in resource-constrained settings using implementation science and health service delivery research methods. Previously she worked as a Research Assistant on the EC Partnership Project and the Prime Study.

Chair

Agenda Item Image
Alisa Pedrana
Senior Research Fellow
Burnet Institute

loading